Related references
Note: Only part of the references are listed.Molecular and physiological functions of sphingosine 1-phosphate transporters
Tsuyoshi Nishi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis
Claudia Raggi et al.
HUMAN MOLECULAR GENETICS (2014)
Cubilin Maintains Blood Levels of HDL and Albumin
Obaidullah Aseem et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Sphingolipids and atherosclerosis
Thorsten Hornemann et al.
ATHEROSCLEROSIS (2013)
Sphingosine 1-Phosphate in Renal Diseases
Alexander Koch et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
High-Density Lipoproteins - Multifunctional but Vulnerable Protections from Atherosclerosis
Wijtske Annema et al.
CIRCULATION JOURNAL (2013)
Apolipoprotein M: bridging HDL and endothelial function
Christina Christoffersen et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies
Jere P. Segrest et al.
JOURNAL OF LIPID RESEARCH (2013)
Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration
Yoshikazu Ono et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Sphingolipid Signaling in Metabolic Disorders
Timothy Hla et al.
CELL METABOLISM (2012)
ABCA1, ABCG1, and SR-BI: Transit of HDL-associated sphingosine-1-phosphate
Xing Liu et al.
CLINICA CHIMICA ACTA (2012)
Endocytic Receptors in the Renal Proximal Tubule
Erik I. Christensen et al.
PHYSIOLOGY (2012)
Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism
Ratna Karuna et al.
ATHEROSCLEROSIS (2011)
Carboxyl Terminus of Apolipoprotein A-I (ApoA-I) Is Necessary for the Transport of Lipid-free ApoA-I but Not Prelipidated ApoA-I Particles through Aortic Endothelial Cells
Pascale M. Ohnsorg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
Christina Christoffersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis
Miguel A. Frias et al.
CARDIOVASCULAR RESEARCH (2010)
An update on sphingosine-1-phosphate and other sphingolipid mediators
Henrik Fyrst et al.
NATURE CHEMICAL BIOLOGY (2010)
Renal phenotype of the cystinosis mouse model is dependent upon genetic background
Nathalie Nevo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Dent's disease
Olivier Devuyst et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
The pathogenesis of cystinosis: mechanisms beyond cystine accumulation
Martijn J. Wilmer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection
Katherine Sattler et al.
CARDIOVASCULAR RESEARCH (2009)
Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes
Naoki Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Serendipitous Fatty Acid Binding Reveals the Structural Determinants for Ligand Recognition in Apolipoprotein M
Madhumati Sevvana et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters
Ryunosuke Ohkawa et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2008)
Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M
K Faber et al.
MOLECULAR ENDOCRINOLOGY (2006)
Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis
C Wolfrum et al.
NATURE MEDICINE (2005)
Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry
EV Berdyshev et al.
ANALYTICAL BIOCHEMISTRY (2005)
Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules
EI Christensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization
XY Zhang et al.
ACTA HISTOCHEMICA (2003)
Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis
SS Wang et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
